Trimipramine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Trimipramine is {{{aOrAn}}} Tricyclic antidepressant that is FDA approved for the {{{indicationType}}} of depression. Common adverse reactions include hypotension, tachycardia, constipation, xerostomia, dizziness, somnolence, blurred vision.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Depression
- 75 mg PO (divided into 1-3 doses per day), increase gradually to 150 mg/day to maximum 200 mg/day for outpatient treatment. Maintenance 50-150 mg/day PO, bedtime, for 3 months.
- 100 mg PO (divided into 1-3 doses per day), increase gradually to 200 mg/day, if unsatisfactory response in in 2-3 weeks, increase to a maximum 300 mg/day for inpatient treatment.
Off-Label Use and Dosage (Adult)
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Depression
- FDA approved for adolescents, not for children.
- 50 mg/day PO may increase up to 100 mg/day for adolescents;
Off-Label Use and Dosage (Pediatric)
Contraindications
- Condition 1
- Condition 2
- Condition 3
- Condition 4
- Condition 5
Warnings
Conidition 1
(Description)
Adverse Reactions
Clinical Trials Experience
Central Nervous System
- (list/description of adverse reactions)
Cardiovascular
- (list/description of adverse reactions)
Respiratory
- (list/description of adverse reactions)
Gastrointestinal
- (list/description of adverse reactions)
Hypersensitive Reactions
- (list/description of adverse reactions)
Miscellaneous
- (list/description of adverse reactions)
Postmarketing Experience
Central Nervous System
- (list/description of adverse reactions)
Cardiovascular
- (list/description of adverse reactions)
Respiratory
- (list/description of adverse reactions)
Gastrointestinal
- (list/description of adverse reactions)
Hypersensitive Reactions
- (list/description of adverse reactions)
Miscellaneous
- (list/description of adverse reactions)
Drug Interactions
- (Drug 1)
- (Description)
- (Drug 2)
- (Description)
- (Drug 3)
- (Description)
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Trimipramine in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Trimipramine in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Trimipramine during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Trimipramine in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Trimipramine in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Trimipramine in geriatric settings.
Gender
There is no FDA guidance on the use of Trimipramine with respect to specific gender populations.
Race
There is no FDA guidance on the use of Trimipramine with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Trimipramine in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Trimipramine in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Trimipramine in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Trimipramine in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Trimipramine Administration in the drug label.
Monitoring
There is limited information regarding Trimipramine Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Trimipramine and IV administrations.
Overdosage
There is limited information regarding Trimipramine overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Trimipramine Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Trimipramine Mechanism of Action in the drug label.
Structure
There is limited information regarding Trimipramine Structure in the drug label.
Pharmacodynamics
There is limited information regarding Trimipramine Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Trimipramine Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Trimipramine Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Trimipramine Clinical Studies in the drug label.
How Supplied
There is limited information regarding Trimipramine How Supplied in the drug label.
Storage
There is limited information regarding Trimipramine Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Trimipramine |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Trimipramine |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Trimipramine Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Trimipramine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Trimipramine Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Trimipramine Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.